Avidity Biosciences Reports Second Quarter 2020 Financial Results and Recent HighlightsPRNewsWire • 08/10/20
Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesPRNewsWire • 06/16/20
Avidity Biosciences prices IPO at $18 a share to raise $259.2 million to fund R&DMarket Watch • 06/12/20